Prosecution Insights
Last updated: October 02, 2026

Xcardia Innovation Ltd.

Technology area: Medical Devices & Mechanical Engineering

2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Xcardia Innovation Ltd. is managing 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are assigned to 2 distinct examiners. Both examiners are located within 1 distinct art unit, centralizing the review of the company's applications within a single specialized group. For a practitioner, this concentration suggests that the company's medical innovations are being evaluated under a consistent set of unit-specific guidelines and internal oversight.

TANNER, JOCELIN C is the busiest examiner for the portfolio, with 1 pending office action. With 2 pending office actions total, the workload is split between the distinct examiners. The concentration of examiners in 1 distinct art unit suggests that the company's innovations are being reviewed in a focused regulatory environment. This requires a prosecution strategy that addresses the specific requirements of the art unit while managing the individual approaches of the assigned examiners to achieve favorable results across the portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
1
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (50%)
Multi-statute (no §101)1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TANNER, JOCELIN C 1 72.2% +34.8%
LONG, SARAH A 1 60.6% +42.6%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18292350 CARDIAC LEAD EXTRACTION DEVICE TANNER, JOCELIN C 23d overdue

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18292350 CARDIAC LEAD EXTRACTION DEVICE TANNER, JOCELIN C 23d overdue
17433701 CARDIAC LEAD EXTRACTION DEVICE LONG, SARAH A —

Top Art Units

Art UnitApps
3771 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18292350 CARDIAC LEAD EXTRACTION DEVICE TANNER, JOCELIN C 3771 §103§112Other Non-Final OA 23d overdue Pending Jan 26, 2024
17433701 CARDIAC LEAD EXTRACTION DEVICE LONG, SARAH A 3771 §103 Final Rejection — Pending Aug 25, 2021

Managing Xcardia Innovation Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month